|
1.
Your research group has expended considerable effort
|
a.
for its efforts to develop biochip technologies for
post-genomic era biomedical research. |
|
2. I
found the results from your recent article, “Effect of Green
Tea Polyphenols on RAW 264.7” |
b.
definitely has much to contribute to our country’s efforts
to elevate its research capacity in this area. |
|
3.
As is well known, your company pioneered
|
c.
to be extremely helpful to my own research direction. |
|
4.
As a global leader in developing medical instrumentation,
your laboratory |
d.
with the report on your radiology department’s capabilities
in processing three-dimensional images. |
|
5.
In this area, your laboratory has acquired much expertise
and relevant data, explaining why I am
|
e.
hold for manufacturing your natural products that adopt the
latest scientific and technological advances, as well as
quality assurance standards. |
|
6.
Given your excellent product quality and strong commitment
to |
f. benefited from your findings on how
Helicobacter pylori can be used in vaccines and medicinal
applications. |
|
7.
During the International Conference on Three-dimensional
Medical Images on Oct 29, I was impressed
|
g.
in treating stroke patients by state-of-the-art
instrumentation aimed at resolve brain ischemia-related
problems. |
|
8.
Your products conform to the most stringent environmental
standards through the use of ingredients |
h.
eagerly looking forward to this upcoming technical visit. |
|
9. As a research unit of Biomedicum
Helsinki, your research center (Biomedicum Biochip Center)
is renowned |
i.
the use of natural plant oil to refine crude oil for use in
daily goods and appliances. |
|
10.
We are most impressed with the number of patented
technologies that you
|
j. of biochip data, while applying the
results of these research efforts to eradicate complex
diseases such as cancer. |
|
11. From your press release dated November
10, 2005 on recent developments to identify protein
functions, I greatly |
k.
adopting advanced environmental protection practices in your
manufacturing processes, |
|
12. We are also impressed with your
innovativeness in performing bioinformatics-based analyses
|
l. that are phosphate-free and
environmentally friendly. |
